Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient"s quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
Website: staar.com



Growth: Pretty weak revenue growth rate 6.7%, there is acceleration compared to average historical growth rates -0.9%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -38.5%. On average the margin is improving steadily. Gross margin is high, +82.2%. In the last quarter the company beat the estimated EPS, +150.0%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 1.5% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 26.6% higher than minimum and 73.8% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -0.3x by EV / Sales multiple

Insiders: For the last 3 months insiders bought company shares on $50.5 mln (3.897% of cap.)

Key Financials (Download financials)

Ticker: STAA
Share price, USD:  (0.0%)19.11
year average price 21.61  


year start price 21.90 2025-02-08

min close price 15.09 2025-04-08

max close price 28.57 2025-08-14

current price 19.11 2026-02-07
Common stocks: 49 633 000

Dividend Yield:  0.0%
Last revenue growth (y/y):  +6.7%
Last growth of EBITDA (y/y):  +185.7%
Historical revenue growth:  -0.9%
Historical growth of EBITDA:  0.0%
EV / Sales: 3.5x
Margin (EBITDA LTM / Revenue): -38.5%
Fundamental value created in LTM:
Market Cap ($m): 948
Net Debt ($m): -137
EV (Enterprise Value): 811
Price to Book: 2.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-30fool.com

New $17 Million Bet on STAAR Surgical Comes as Sales Jump 7% and Margins Hit 82%

2025-12-16businesswire.com

Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory

2025-10-22reuters.com

Staar Surgical's top investor calls shareholder meeting to remove directors

2025-09-29prnewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders

2025-09-27globenewswire.com

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders

2025-09-24globenewswire.com

STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options

2025-09-15businesswire.com

Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders

2025-08-11zacks.com

Staar Surgical (STAA) International Revenue in Focus: Trends and Expectations

2025-08-07prnewswire.com

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of STAAR Surgical Company (NASDAQ: STAA)

2025-08-05globenewswire.com

STAA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of STAAR Surgical to Alcon
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-26 2025-06-27 2024-12-27 2024-09-27 2024-06-28 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31 2022-12-30 2022-09-30 2021-12-31 2021-01-01
symbol STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937
fillingDate 2025-11-05 2025-08-06 2024-10-30 2024-08-07 2024-05-07 2023-11-06 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-11-05 16:06:04 2025-08-06 16:05:55 2025-02-21 16:00:40 2024-10-30 16:08:13 2024-08-07 16:06:04 2024-05-07 16:11:10 2024-02-27 06:04:44 2023-11-06 06:05:24 2023-08-02 16:11:49 2023-05-03 16:12:08 2023-02-22 21:32:23 2022-11-02 16:11:28 2022-02-23 16:21:49 2021-02-24 16:15:59
calendarYear 2025 2025 2024 2024 2024 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q1 Q4 FY Q3 FY FY
revenue 95M 44M 314M 89M 99M 77M 322M 80M 92M 74M 284M 76M 230M 163M
costOfRevenue 17M 12M 74M 20M 21M 16M 70M 17M 22M 16M 61M 16M 52M 45M
grossProfit 78M 33M 240M 68M 78M 61M 253M 64M 71M 58M 223M 60M 179M 118M
grossProfitRatio 0.822 0.74 0.773 0.792 0.789 0.792 0.766 0.783 0.795
researchAndDevelopmentExpenses 9M 10M 54M 14M 14M 13M 44M 11M 12M 10M 36M 10M 34M 32M
generalAndAdministrativeExpenses 21M 21M 90M 22M 24M 23M 72M 19M 18M 18M 55M 14M 44M 34M
sellingAndMarketingExpenses 23M 26M 108M 27M 29M 27M 108M 27M 32M 26M 89M 23M 67M 46M
sellingGeneralAndAdministrativeExpenses 44M 47M 198M 48M 52M 50M 180M 46M 50M 44M 144M 37M 111M 80M
otherExpenses 6M 5M 0 0 63 000 838 000 0 145 000 10000 63 000 0 0 0 0
operatingExpenses 59M 63M 252M 63M 67M 63M 225M 57M 62M 55M 180M 47M 145M 112M
costAndExpenses 76M 74M 327M 83M 87M 80M 294M 74M 84M 71M 241M 62M 197M 157M
interestIncome 790 000 1M 6M 0 1M 2M 7M 2M 2M 0 2M 0 238 000
interestExpense 0 0 0 0 0 0 0 0 0 2M 0 897 000 38 000 0
depreciationAndAmortization 2M 2M 7M 2M 2M 1M 5M 1M 1M 1M 5M 853 000 4M 3M
ebitda 26M -23M -6M 7M 13M -1M 33M 9M 12M 4M 48M 15M 37M 10M
ebitdaratio 0.279 -0.513 0.084 0.136 -0.013 0.112 0.129 0.053 0.191
operatingIncome 18M -30M -13M 6M 12M -2M 28M 6M 9M 3M 44M 14M 33M 7M
operatingIncomeRatio 0.195 -0.676 0.064 0.12 -0.029 0.078 0.093 0.038 0.18
totalOtherIncomeExpensesNet 300 000 4M 4M 7M -2M 70 000 6M -1M -2M 2M 2M -1M -2M 1M
incomeBeforeTax 19M -26M -9M 13M 10M -2M 34M 7M 8M 5M 46M 13M 31M 8M
incomeBeforeTaxRatio 0.198 -0.585 0.149 0.104 -0.029 0.084 0.092 0.064 0.165
incomeTaxExpense 10M -9M 11M 3M 3M 1M 12M 2M 2M 2M 6M 2M 4M 2M
netIncome 9M -17M -20M 10M 7M -3M 21M 5M 6M 3M 40M 10M 28M 6M
netIncomeRatio 0.094 -0.379 0.113 0.075 -0.043 0.06 0.066 0.037 0.135
eps 0.18 -0.34 -0.41 0.2 0.15 -0.068 0.44 0.099 0.13 0.06 0.83 0.21 0.52 0.13
epsdiluted 0.18 -0.34 0.2 0.15 -0.068 0.098 0.12 0.05 0.21
weightedAverageShsOut 50M 50M 49M 49M 49M 49M 49M 49M 48M 48M 48M 48M 47M 46M
weightedAverageShsOutDil 50M 50M 49M 50M 50M 49M 49M 49M 50M 50M 49M 50M 49M 48M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-27 2023-02-23 2022-02-23 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 6M 7M 2M -38 000 238 000
ebit -13M 28M 44M 33M 7M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations -20M 21M 40M 28M 6M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -20M 21M 40M 28M 6M
epsDiluted -0.41 0.43 0.8 0.5 0.12

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-11-05 2025-06-27 2024-12-27 2024-09-27 2024-06-28 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31 2022-12-30 2022-09-30 2021-12-31 2021-01-01
symbol STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937
fillingDate 2025-11-05 2025-08-06 2024-10-30 2024-08-07 2024-05-07 2023-11-06 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-11-05 16:02:30 2025-08-06 16:05:55 2025-02-21 16:00:40 2024-10-30 16:08:13 2024-08-07 16:06:04 2024-05-07 16:11:10 2024-02-27 06:04:44 2023-11-06 06:05:24 2023-08-02 16:11:49 2023-05-03 16:12:08 2023-02-22 21:32:23 2022-11-02 16:11:28 2022-02-23 16:21:49 2021-02-24 16:15:59
calendarYear 2025 2025 2024 2024 2024 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q1 Q4 FY Q3 FY FY
cashAndCashEquivalents 176M 167M 144M 164M 193M 224M 183M 127M 95M 90M 86M 129M 200M 152M
shortTermInvestments 17M 23M 86M 72M 42M 21M 38M 61M 97M 114M 125M 82M 0 0
cashAndShortTermInvestments 193M 190M 230M 236M 235M 245M 221M 188M 192M 204M 212M 211M 200M 152M
netReceivables 64M 37M 79M 108M 96M 68M 98M 112M 94M 63M 66M 58M 47M 35M
inventory 53M 53M 43M 40M 39M 39M 35M 31M 25M 28M 24M 20M 17M 18M
otherCurrentAssets 12M 13M 980 000 13M 14M 14M 7M 16M 16M 132M 811 000 8M 636 000 5M
totalCurrentAssets 321M 293M 368M 397M 384M 366M 365M 347M 328M 313M 312M 297M 271M 216M
propertyPlantEquipmentNet 104M 107M 122M 120M 113M 107M 101M 98M 88M 85M 82M 78M 68M 33M
goodwill 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
intangibleAssets 0 0 0 0 0 0 0 0 0 165 000 173 000 171 000 218 000 270 000
goodwillAndIntangibleAssets 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
longTermInvestments 0 0 0 0 265 000 7M 12M 14M 18M 13M 14M 13M 0 0
taxAssets 2M 12M 788 000 5M 5M 5M 5M 9M 5M 5M 9M 4M 4M 5M
otherNonCurrentAssets 27M 24M 17M 14M 9M 6M 3M 2M 954 000 956 000 957 000 808 000 822 000 608 000
totalNonCurrentAssets 135M 145M 142M 140M 129M 127M 123M 124M 113M 106M 107M 98M 74M 41M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 456M 438M 510M 538M 513M 493M 489M 472M 441M 419M 419M 395M 346M 257M
accountPayables 9M 12M 17M 15M 19M 17M 14M 9M 11M 9M 12M 8M 9M 3M
shortTermDebt 5M 5M 0 5M 10M 5M 0 4M 4M 4M 0 4M 0 1M
taxPayables 1M 1M 7M 7M 5M 10M 11M 9M 7M 5M 4M 5M 2M 6M
deferredRevenue 0 0 0 0 5M 10M 0 0 7M 0 0 0 0 5M
otherCurrentLiabilities 46M 41M 24M 40M 32M 32M 21M 44M 32M 34M 22M 34M 22M 9M
totalCurrentLiabilities 62M 59M 70M 66M 66M 63M 65M 57M 54M 47M 52M 45M 49M 41M
longTermDebt 34M 35M 0 35M 31M 31M 0 32M 28M 28M 0 26M 0 0
deferredRevenueNonCurrent 0 0 0 0 -1 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 297 000 1M 1M 1M 1M 1M 1M 1M 1M 2M 811 000 222 000
otherNonCurrentLiabilities 7M 7M 7M 7M 5M 5M 5M 3M 3M 3M 2M 18M 9M 12M
totalNonCurrentLiabilities 41M 42M 42M 43M 37M 37M 38M 36M 33M 33M 31M 29M 38M 19M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 39M 41M 39M 35M 36M 31M 36M 36M 32M 32M 31M 30M 32M 9M
totalLiabilities 103M 101M 112M 109M 104M 100M 103M 93M 87M 80M 83M 75M 87M 60M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 497 000 495 000 493 000 493 000 492 000 491 000 488 000 488 000 485 000 483 000 482 000 482 000 477 000 464 000
retainedEarnings -130M -139M -68M -33M -43M -51M -47M -55M -64M -70M -69M -78M -111M -136M
accumulatedOtherComprehensiveIncomeLoss -7M -6M -7M -6M -5M -5M -4M -3M -3M -937 000 156 000 -310 000 -4M -6M
othertotalStockholdersEquity 490M 480M 467M 457M 448M 436M 420M 409M 398M
totalStockholdersEquity 354M 337M 397M 428M 409M 393M 386M 379M 354M 339M 336M 320M 259M 197M
totalEquity 354M 337M 397M 428M 409M 393M 386M 379M 354M 339M 336M 320M 259M 197M
totalLiabilitiesAndStockholdersEquity 456M 438M 538M 513M 493M 472M 441M 419M 395M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 456M 438M 510M 538M 513M 493M 489M 472M 441M 419M 419M 395M 346M 257M
totalInvestments 17M 23M 86M 72M 43M 28M 49M 74M 18M 13M 139M 95M 0 0
totalDebt 39M 41M 39M 40M 36M 36M 36M 36M 32M 32M 31M 30M 32M 11M
netDebt -137M -127M -105M -124M -157M -188M -147M -92M -62M -58M -55M -99M -168M -142M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-27 2023-02-23 2022-02-23 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 78M 95M 62M 44M 35M
otherReceivables 1M 3M 4M 3M 0
prepaids 14M 4M 9M 7M 6M
totalPayables 23M 24M 15M 11M 7M
otherPayables 7M 11M 4M 2M 5M
accruedExpenses 19M 15M 11M 12M 16M
capitalLeaseObligationsCurrent 4M 4M 4M 3M 3M
capitalLeaseObligationsNonCurrent 35M 31M 27M 29M 7M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 471M 437M 404M 374M 338M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2033 q1 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2033-05-01 2025-11-05 2025-06-27 2024-12-27 2024-09-27 2024-06-28 2024-03-29 2023-12-29 2023-09-29 2023-06-30 2023-03-31 2022-12-30 2022-09-30 2021-12-31 2021-01-01
symbol STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA STAA
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937 718 937
fillingDate 2022-11-02 2025-11-05 2025-08-06 2024-10-30 2024-08-07 2024-05-07 2023-11-06 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2022-11-02 16:06:55 2025-11-05 16:02:30 2025-08-06 16:05:55 2025-02-21 16:00:40 2024-10-30 16:08:13 2024-08-07 16:06:04 2024-05-07 16:11:10 2024-02-27 06:04:44 2023-11-06 06:05:24 2023-08-02 16:11:49 2023-05-03 16:12:08 2023-02-22 21:32:23 2022-11-02 16:11:28 2022-02-23 16:21:49 2021-02-24 16:15:59
calendarYear 2033 2025 2025 2024 2024 2024 2023 2023 2022 2022
period Q1 Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q1 Q4 FY Q3 FY FY
netIncome 4000 9M -17M -20M 10M 7M -3M 21M 5M 6M 3M 39M 10M 28M 6M
depreciationAndAmortization 0 2M 2M 7M 2M 2M 1M 5M 1M 1M 1M 5M 1M 4M 3M
deferredIncomeTax 0 10M -10M 4M -13 000 -1000 61 000 3M -10000 18 000 57 000 -1M 23 000 -2M -849 000
stockBasedCompensation 0 8M 8M 27M 7M 9M 6M 24M 9M 8M 6M 20M 6M 15M 12M
changeInWorkingCapital 0 -31M -16M -5M 13M -30M 17M -41M -22M -25M -14M -29M 7M -2M -3M
accountsReceivables 0 -26M 6M 16 493 -10M -29M 30M -33M -18M -31M -1M -20M 7M -9M -4M
inventory 0 -1M -5M -10000 -1M -869 000 -4M -14M -6M -462 000 -4M -8M -2M 66 000 -1M
accountsPayables 0 -2M 537 000 75 -6M 2M 2M -701 000 -2M 2M -3M 2M -5M 108 000 -1M
otherWorkingCapital 0 -1M -17M -5M 30M -1M -11M 7M 4M 5M 8M -3M 8M 6M 4M
otherNonCashItems -4000 5M 5M 4M -28M 41M -18M 2M 914 000 3M -759 000 2M -166 000 2M 3M
netCashProvidedByOperatingActivities 4000 3M -27M 16M 4M -10M 22M 15M -6M -6M -5M 36M 24M 44M 21M
investmentsInPropertyPlantAndEquipment 0 -883 000 -2M -23M 11M -6M -5M -18M -9M -3M -3M -18M -6M -14M -8M
acquisitionsNet 0 0 0 0 0 0 0 0 -41M 0 2M 138M 0 0 0
purchasesOfInvestments 0 -12M 0 -80M -41M -20M 0 -52M -10M -15M -27M -156M 0 0 0
salesMaturitiesOfInvestments 0 18M 27M 44M 12M 6M 21M 145M 51M 28M 40M 17M 0 0 0
otherInvestingActivites 0 0 0 -18M -14M -5M 41M 0 -2M -96M
netCashUsedForInvestingActivites 0 5M 25M -35M -21M 16M 32M 10M 10M -102M
debtRepayment 0 0 0 -42 000 -42 000 -40 000 -39 000 -40 000 -42 000 -40 000
commonStockIssued 0 1000 12 000 2M 0 5M 7M 0 1000 0
commonStockRepurchased 0 -2M -4M -2M 0 -167 000 -1M -2M -112 000 -135 000 -2M 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 3M -73 000 2M 370 000 -1M 7M 1M 529 000 5M
netCashUsedProvidedByFinancingActivities 0 983 000 -5M 2M 163 000 4M 7M 1M -1M 5M
effectOfForexChangesOnCash 0 91 000 686 000 -1M 1M -330 000 -937 000 202 000 -235 000 -441 000 10000 -862 000 -502 000 -857 000 367 000
netChangeInCash 4000 9M -6M -39M -29M -31M 41M 97M 33M 5M 3M -113M -73M 47M 32M
cashAtEndOfPeriod 4000 176M 167M 144M 164M 193M 224M 183M 127M 95M 90M 86M 129M 200M 152M
cashAtBeginningOfPeriod 0 167M 173M 183M 193M 224M 183M 86M 95M 90M 86M 200M 202M 152M 120M
operatingCashFlow 4000 3M -27M 16M 4M -10M 22M 15M -6M -6M -5M 36M 24M 44M 21M
capitalExpenditure 0 -883 000 -2M -23M 11M -6M -5M -18M -9M -3M -3M -18M -6M -14M -8M
freeCashFlow 4000 2M -29M -8M 15M -17M 16M -4M -15M -9M -8M 18M 18M 30M 13M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-27 2023-02-23 2022-02-23 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 -138M 0 0
netCashProvidedByInvestingActivities -59M 74M -156M -14M -8M
netDebtIssuance -165 000 -161 000 -126 000 -2M -1M
longTermNetDebtIssuance -165 000 -161 000 -126 000 -348 000 -561 000
shortTermNetDebtIssuance 0 0 0 -1M -515 000
netStockIssuance -2M -2M 1000 1000 1000
netCommonStockIssuance -2M -2M 1000 1000 1000
commonStockIssuance 2000 1000 1000 1000 1000
netPreferredStockIssuance 0 -1000 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 7M 10M 8M 19M 21M
netCashProvidedByFinancingActivities 6M 7M 8M 18M 20M
incomeTaxesPaid 11M 3M 7M 7M 0
interestPaid 87 000 75 000 52 000 75 000 0

Earning call transcript

2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-02-13 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-02-26 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-21 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-10 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-07 12:39 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-11-07 12:39 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-11-07 12:39 ET
STAAR Surgical Co published news for 2025 q3
SEC form 10
2025-11-05 21:06 ET
STAAR Surgical Co reported for 2025 q3
SEC form 8
2025-11-05 21:02 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-11-05 21:02 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-27 14:52 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-27 14:52 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-23 20:21 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-23 20:21 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-20 11:45 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-10-20 11:45 ET
STAAR Surgical Co published news for 2025 q3
SEC form 8
2025-09-26 13:14 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-09-26 13:14 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-09-26 13:14 ET
STAAR Surgical Co published news for 2025 q2
SEC form 10
2025-08-06 20:05 ET
STAAR Surgical Co reported for 2025 q2
SEC form 8
2025-08-06 20:02 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-08-06 20:02 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-08-05 12:37 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-08-05 12:37 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-08-05 12:37 ET
STAAR Surgical Co published news for 2025 q2
SEC form 8
2025-06-04 11:00 ET
STAAR Surgical Co published news for 2025 q1
SEC form 8
2025-06-04 11:00 ET
STAAR Surgical Co published news for 2025 q1
SEC form 8
2025-05-16 11:00 ET
STAAR Surgical Co published news for 2025 q1
SEC form 8
2025-05-16 11:00 ET
STAAR Surgical Co published news for 2025 q1
SEC form 10
2025-05-07 20:11 ET
STAAR Surgical Co reported for 2025 q1
SEC form 8
2025-05-07 20:02 ET
STAAR Surgical Co published news for 2025 q1
SEC form 8
2025-05-07 20:02 ET
STAAR Surgical Co reported for 2025 q1
SEC form 8
2025-05-07 20:02 ET
STAAR Surgical Co published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
STAAR Surgical Co reported for 2025 q1
SEC form 10
2025-02-21 21:00 ET
STAAR Surgical Co published news for 2024 q4
SEC form 10
2025-02-21 00:00 ET
STAAR Surgical Co published news for 2024 q4
SEC form 8
2025-02-11 00:00 ET
STAAR Surgical Co published news for 2024 q4
SEC form 8
2025-02-11 00:00 ET
STAAR Surgical Co reported for 2024 q4
SEC form 8
2025-02-11 00:00 ET
STAAR Surgical Co published news for 2024 q4
SEC form 8
2024-10-31 06:04 ET
STAAR Surgical Co published news for 2024 q3
SEC form 8
2024-10-31 06:04 ET
STAAR Surgical Co published news for 2024 q3
SEC form 8
2024-10-31 06:04 ET
STAAR Surgical Co published news for 2024 q3
SEC form 10
2024-10-30 16:08 ET
STAAR Surgical Co reported for 2024 q3
SEC form 10
2024-10-30 00:00 ET
STAAR Surgical Co published news for 2024 q3
SEC form 8
2024-10-30 00:00 ET
STAAR Surgical Co published news for 2024 q3
SEC form 8
2024-10-30 00:00 ET
STAAR Surgical Co published news for 2024 q3
SEC form 8
2024-10-30 00:00 ET
STAAR Surgical Co published news for 2024 q3
SEC form 10
2024-08-07 16:06 ET
STAAR Surgical Co reported for 2024 q2
SEC form 8
2024-08-07 16:03 ET
STAAR Surgical Co published news for 2024 q2
SEC form 8
2024-08-07 16:03 ET
STAAR Surgical Co published news for 2024 q2
SEC form 8
2024-08-07 16:03 ET
STAAR Surgical Co published news for 2024 q2
SEC form 10
2024-08-07 00:00 ET
STAAR Surgical Co published news for 2024 q2
SEC form 10
2024-05-07 16:11 ET
STAAR Surgical Co reported for 2024 q1
SEC form 8
2024-05-07 16:03 ET
STAAR Surgical Co published news for 2024 q1
SEC form 8
2024-05-07 16:03 ET
STAAR Surgical Co reported for 2024 q1
SEC form 8
2024-05-07 16:03 ET
STAAR Surgical Co published news for 2024 q1
SEC form 10
2024-05-07 00:00 ET
STAAR Surgical Co published news for 2024 q1
SEC form 8
2024-04-04 00:00 ET
STAAR Surgical Co published news for 2024 q1
SEC form 8
2024-04-04 00:00 ET
STAAR Surgical Co published news for 2024 q1
SEC form 10
2024-02-27 06:04 ET
STAAR Surgical Co published news for 2023 q4
SEC form 10
2024-02-27 00:00 ET
STAAR Surgical Co published news for 2023 q4
SEC form 8
2024-02-26 16:04 ET
STAAR Surgical Co published news for 2023 q4
SEC form 8
2024-02-26 16:04 ET
STAAR Surgical Co reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
STAAR Surgical Co published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
STAAR Surgical Co published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
STAAR Surgical Co published news for 2023 q4
SEC form 10
2023-11-06 00:00 ET
STAAR Surgical Co published news for 2023 q3
SEC form 8
2023-11-01 16:11 ET
STAAR Surgical Co reported for 2023 q3
SEC form 6
2023-08-03 16:42 ET
STAAR Surgical Co published news for 2023 q2
SEC form 10
2023-08-02 16:11 ET
STAAR Surgical Co reported for 2023 q2
SEC form 6
2023-08-02 16:06 ET
STAAR Surgical Co published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
STAAR Surgical Co published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
STAAR Surgical Co published news for 2023 q2
SEC form 6
2023-06-16 17:14 ET
STAAR Surgical Co published news for 2023 q1
SEC form 6
2023-06-07 16:07 ET
STAAR Surgical Co published news for 2023 q1
SEC form 6
2023-06-06 06:59 ET
STAAR Surgical Co published news for 2023 q1
SEC form 10
2023-05-03 00:00 ET
STAAR Surgical Co published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
STAAR Surgical Co published news for 2023 q1
SEC form 6
2023-03-29 07:00 ET
STAAR Surgical Co published news for 2022 q4
SEC form 6
2023-03-14 10:45 ET
STAAR Surgical Co published news for 2022 q4
SEC form 10
2023-02-23 00:00 ET
STAAR Surgical Co reported for 2022 q4
SEC form 10
2023-02-22 21:32 ET
STAAR Surgical Co reported for 2022 q4
SEC form 6
2023-02-22 20:06 ET
STAAR Surgical Co published news for 2022 q4
SEC form 6
2023-02-21 16:06 ET
STAAR Surgical Co published news for 2022 q4
SEC form 8
2023-02-21 00:00 ET
STAAR Surgical Co reported for 2022 q4
SEC form 6
2023-02-01 16:30 ET
STAAR Surgical Co published news for 2022 q4
SEC form 6
2023-01-09 08:00 ET
STAAR Surgical Co published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
STAAR Surgical Co published news for 2022 q4
SEC form 6
2022-12-19 06:05 ET
STAAR Surgical Co published news for 2022 q3
SEC form 6
2022-11-03 16:06 ET
STAAR Surgical Co published news for 2022 q3
SEC form 10
2022-11-02 16:11 ET
STAAR Surgical Co reported for 2022 q3
SEC form 6
2022-11-02 16:06 ET
STAAR Surgical Co published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
STAAR Surgical Co reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
STAAR Surgical Co reported for 2022 q3
SEC form 6
2022-08-11 16:07 ET
STAAR Surgical Co published news for 2022 q2
SEC form 10
2022-08-10 16:15 ET
STAAR Surgical Co reported for 2022 q2
SEC form 6
2022-08-10 16:10 ET
STAAR Surgical Co published news for 2022 q2
SEC form 10
2022-08-10 00:00 ET
STAAR Surgical Co reported for 2022 q2
SEC form 8
2022-08-10 00:00 ET
STAAR Surgical Co reported for 2022 q2
SEC form 6
2022-07-20 17:00 ET
STAAR Surgical Co published news for 2022 q2
SEC form 6
2022-06-17 16:27 ET
STAAR Surgical Co published news for 2022 q1
SEC form 6
2022-06-07 08:00 ET
STAAR Surgical Co published news for 2022 q1
SEC form 6
2022-05-05 19:44 ET
STAAR Surgical Co published news for 2022 q1
SEC form 10
2022-05-04 16:14 ET
STAAR Surgical Co reported for 2022 q1
SEC form 6
2022-05-04 16:12 ET
STAAR Surgical Co published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
STAAR Surgical Co reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
STAAR Surgical Co reported for 2022 q1
SEC form 6
2022-04-29 16:33 ET
STAAR Surgical Co published news for 2022 q1
SEC form 6
2022-04-13 16:34 ET
STAAR Surgical Co published news for 2022 q1
SEC form 6
2022-04-06 08:00 ET
STAAR Surgical Co published news for 2022 q1
SEC form 6
2022-03-28 08:01 ET
STAAR Surgical Co published news for 2021 q4
SEC form 6
2022-02-24 16:06 ET
STAAR Surgical Co published news for 2021 q4
SEC form 6
2022-02-23 17:22 ET
STAAR Surgical Co published news for 2021 q4
SEC form 10
2022-02-23 16:21 ET
STAAR Surgical Co published news for 2021 q4
SEC form 10
2022-02-23 00:00 ET
STAAR Surgical Co published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
STAAR Surgical Co published news for 2021 q4
SEC form 6
2022-02-01 08:46 ET
STAAR Surgical Co published news for 2021 q4
SEC form 6
2022-01-10 09:01 ET
STAAR Surgical Co published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
STAAR Surgical Co published news for 2021 q4
SEC form 6
2021-11-04 17:00 ET
STAAR Surgical Co published news for 2021 q3
SEC form 10
2021-11-03 16:16 ET
STAAR Surgical Co published news for 2021 q3
SEC form 6
2021-11-03 16:11 ET
STAAR Surgical Co published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
STAAR Surgical Co published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
STAAR Surgical Co published news for 2021 q3
SEC form 6
2021-09-24 16:05 ET
STAAR Surgical Co published news for 2021 q2
SEC form 6
2021-08-09 20:22 ET
STAAR Surgical Co published news for 2021 q2
SEC form 6
2021-08-05 16:12 ET
STAAR Surgical Co published news for 2021 q2
SEC form 10
2021-08-04 16:13 ET
STAAR Surgical Co published news for 2021 q2
SEC form 6
2021-08-04 16:10 ET
STAAR Surgical Co published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
STAAR Surgical Co published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
STAAR Surgical Co published news for 2021 q2
SEC form 6
2021-06-25 16:06 ET
STAAR Surgical Co published news for 2021 q1
SEC form 6
2021-05-26 18:08 ET
STAAR Surgical Co published news for 2021 q1
SEC form 6
2021-05-06 16:25 ET
STAAR Surgical Co published news for 2021 q1
SEC form 10
2021-05-05 16:11 ET
STAAR Surgical Co published news for 2021 q1
SEC form 6
2021-05-05 16:06 ET
STAAR Surgical Co published news for 2021 q1
SEC form 10
2021-05-05 00:00 ET
STAAR Surgical Co published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
STAAR Surgical Co published news for 2021 q1
SEC form 6
2021-04-30 08:01 ET
STAAR Surgical Co published news for 2021 q1
SEC form 6
2021-02-25 14:03 ET
STAAR Surgical Co published news for 2020 q4
SEC form 10
2021-02-24 16:15 ET
STAAR Surgical Co published news for 2020 q4
SEC form 6
2021-02-24 16:10 ET
STAAR Surgical Co published news for 2020 q4
SEC form 6
2021-01-26 12:42 ET
STAAR Surgical Co published news for 2020 q4
SEC form 6
2021-01-11 06:03 ET
STAAR Surgical Co published news for 2020 q4
SEC form 6
2020-11-05 16:51 ET
STAAR Surgical Co published news for 2020 q3
SEC form 10
2020-11-04 16:10 ET
STAAR Surgical Co published news for 2020 q3
SEC form 6
2020-11-04 16:06 ET
STAAR Surgical Co published news for 2020 q3
SEC form 6
2020-10-07 20:03 ET
STAAR Surgical Co published news for 2020 q3